The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
ESVM Guideline on peripheral arterial disease
Open accessAbstract
Chapter 2: Epidemiology c It is recommended that recognition be given that patients with PAD have a high risk of vascular events in other vascular beds.(Evidence Level A), and as such these patients should always be considered high risk for further events.(Level A, class I) 12 c In patients with PAD, it is recommended that optimization of treatment of the concomitant coronary artery disease and cardiac failure should be undertaken.(Evidence Level B, class I) 12 c It is recommended that in patients with renal failure, that attention be paid to the concomitant presence of arteriosclerosis (atherosclerosis plus calcification) in the lower limb, as such disease in this patient population has a poorer prognosis.(Evidence Level B, Recommendation class I) 13 Chapter 3: Diagnosis of peripheral arterial disease c It is recommended to perform clinical examination of the feet regularly in patients with PAD.(Evidence level C, recommendation level I) 17 c It is recommended that ABI values 6 0.9 are evidence of clinically significant PAD.(Evidence level B, recommendation level I) 17 c In patients with trophic disorders, diabetes mellitus and in all those with an ABI score of [ 1.3, toe pressure measurements and calculation of the toe-brachial Index are recommended to detect PAD (because of proven or susprected medial sclerosis of the lower limb arteries).(Consensus recommendation, Evidence level C, Recommendation class I) 19 Chapter 4: Therapy for peripheral arterial disease -
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citation(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Cited by
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Mazzolai, L., Teixido-Tura, G., Lanzi, S., Boc, V., Bossone, E., Brodmann, M., Bura-Rivière, A., De Backer, J., Deglise, S., Della Corte, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae179 · Cited by 993
Self-citationNordanstig, J., Behrendt, C.-A., Baumgartner, I., Belch, J., Bäck, M., Fitridge, R., Hinchliffe, R., Lejay, A., Mills, J. L., Rother, U., et al. (2024) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.08.067 · Cited by 515
Self-citationGerdts (2022) · doi:10.1093/eurheartj/ehac470 · Cited by 241
Fitridge, R., Chuter, V., Mills, J., Hinchliffe, R., Azuma, N., Behrendt, C., Boyko, E. J., Conte, M. S., Humphries, M., Kirksey, L., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3686 · Cited by 201
Self-citation
Metadata
- Authors
- Frank, U., Nikol, S., Belch, J., Boc, V., Brodmann, M., Carpentier, P. H., Chraim, A., Canning, C., Dimakakos, E., Gottsäter, A., Heiss, C., Mazzolai, L., Madaric, J., Olinic, D. M., Pécsvárady, Z., Poredoš, P., Quéré, I., Roztocil, K., Stanek, A., Vasic, D., Visonà, A., Wautrecht, J.-C., Bulvas, M., Colgan, M.-P., Dorigo, W., Houston, G., Kahan, T., Lawall, H., Lindstedt, I., Mahe, G., Martini, R., Pernod, G., Przywara, S., Righini, M., Schlager, O., & Terlecki, P.
- Venue
- Vasa
- Publisher
- Hogrefe Publishing Group
- Published
- 2019-12
- Volume
- 48
- Issue
- Supplement 102
- Pages
- 1-79
- ISSN
- 0301-1526 (ISSN-L)
- 1664-2872
- OpenAlex
- W2992284282
- Cited by
- 250
- References
- 54
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ESVM Guideline on peripheral arterial disease. https://app.cochat.ai/papers/10.1024/0301-1526/a000834
- The paper
- Frank, U., Nikol, S., Belch, J., Boc, V., Brodmann, M., Carpentier, P. H., Chraim, A., Canning, C., Dimakakos, E., Gottsäter, A., Heiss, C., Mazzolai, L., Madaric, J., Olinic, D. M., Pécsvárady, Z., Poredoš, P., Quéré, I., Roztocil, K., Stanek, A., . . . Terlecki, P. (2019). ESVM Guideline on peripheral arterial disease. Vasa. https://doi.org/10.1024/0301-1526/a000834
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.